SCHEMBL10176189

SCHEMBL10176189

CCc1ccc(-c2c(C)nn(C)c2C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51
HTR7 P34969 2/20 0.48
HTR1A P08908 1/20 0.48
CYP1A2 P05177 2/20 0.42
MAPT P10636 2/20 0.42
PRMT5 O14744 1/20 0.42
WDR77 Q9BQA1 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
HIF1A Q16665 1/20 0.42
AXL P30530 1/20 0.41
FLT3 P36888 1/20 0.41
MERTK Q12866 1/20 0.41
TDP2 O95551 2/20 0.40
CREBBP Q92793 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12944870 0.81 MAPT (0.47) SMN1; SMN2LMNAHTR7HTR1ACYP1A2
SCHEMBL12362814 0.78 HTR7 (0.51) SMN1; SMN2HTR7HTR1AMAPTPRMT5
SCHEMBL20320421 0.77 MAPT (0.67) SMN1; SMN2LMNAHTTHTR7HTR1A
SCHEMBL10145036 0.75 HTR7 (0.43) SMN1; SMN2HTR7HTR1AMAPTPRMT5
SCHEMBL14996675 0.75 SMN1; SMN2 (0.44) SMN1; SMN2LMNAHTTCYP1A2MAPT
SCHEMBL10176300 0.75 HTR7 (0.43) SMN1; SMN2LMNAHTR7HTR1ACYP1A2
SCHEMBL19368997 0.72 HTR7 (0.41) HTR7HTR1ACYP1A2MAPTPRMT5
SCHEMBL31617583 0.72 SMN1; SMN2 (0.42) SMN1; SMN2LMNAHTTCYP1A2MAPT
SCHEMBL2828496 0.69 HTR7 (0.67) HTR7HTR1AMAPTPRMT5WDR77
SCHEMBL4021817 0.69 MAPT (0.44) HTR7HTR1AMAPTPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115869-A1 TETRAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115869-A1 TETRAZOLE DERIVATIVES TSLP, IL5, CMA1 SMN1; SMN2 3831/4885LMNA 4204/4885HTT 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.